Multicystic dedifferentiated retroperitoneal liposarcoma: tumour cyst fluid analysis and implications for management
暂无分享,去创建一个
R. Benjamin | R. Pollock | P. Pisters | B. Amini | L. Radvanyi | G. Sim | M. Harao | M. Khoury | W. Tseng
[1] P. Hwu,et al. Analysis of the Intratumoral Adaptive Immune Response in Well Differentiated and Dedifferentiated Retroperitoneal Liposarcoma , 2015, Sarcoma.
[2] S. Singhal,et al. Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer. , 2014, The Journal of clinical investigation.
[3] V. Bronte,et al. Myeloid‐derived suppressor cell heterogeneity in human cancers , 2014, Annals of the New York Academy of Sciences.
[4] Atique U. Ahmed,et al. Depletion of myeloid-derived suppressor cells during interleukin-12 immunogene therapy does not confer a survival advantage in experimental malignant glioma , 2014, Cancer Gene Therapy.
[5] L. Dodd. Update on Liposarcoma: A review for cytopathologists , 2012, Diagnostic cytopathology.
[6] Hyun-Jeong Ko,et al. The restoration of myeloid‐derived suppressor cells as functional antigen‐presenting cells by NKT cell help and all‐trans‐retinoic acid treatment , 2012, International journal of cancer.
[7] A. Lazar,et al. Lymphocyte composition and distribution in inflammatory, well-differentiated retroperitoneal liposarcoma: clues to a potential adaptive immune response and therapeutic implications. , 2012, The American journal of surgical pathology.
[8] V. Bronte,et al. Myeloid-derived suppressor cell heterogeneity and subset definition. , 2010, Current opinion in immunology.
[9] J. Coindre,et al. Well-differentiated and dedifferentiated liposarcomas , 2010, Virchows Archiv.
[10] Marc E. Rothenberg,et al. Regulation of Carcinogenesis by IL-5 and CCL11: A Potential Role for Eosinophils in Tumor Immune Surveillance1 , 2007, The Journal of Immunology.
[11] Christopher Chiu,et al. Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis , 2006, Proceedings of the National Academy of Sciences.
[12] J. Thomas,et al. Surgical management of primary and recurrent retroperitoneal liposarcoma , 2005, The British journal of surgery.
[13] K. Hoag,et al. Physiological concentrations of retinoic acid favor myeloid dendritic cell development over granulocyte development in cultures of bone marrow cells from mice. , 2004, The Journal of nutrition.
[14] Bin Yu,et al. All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination. , 2003, Cancer research.
[15] A. Horiguchi,et al. [Perinephric liposarcoma mimicking cystic renal tumor]. , 2002, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.
[16] R. Pollock,et al. Soft Tissue Sarcomas , 2001, CA: a cancer journal for clinicians.
[17] D. Shibata,et al. Is there a role for incomplete resection in the management of retroperitoneal liposarcomas? , 2001, Journal of the American College of Surgeons.
[18] R. Benjamin,et al. Phase II clinical investigation of gemcitabine in advanced soft tissue sarcomas and window evaluation of dose rate on gemcitabine triphosphate accumulation. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] D. Gabrilovich,et al. Mechanism of Immune Dysfunction in Cancer Mediated by Immature Gr-1+ Myeloid Cells1 , 2001, The Journal of Immunology.
[20] J. Posen,et al. Lymphocyte-rich pleural liposarcoma mimicking pericardial cyst. , 2000, The Journal of thoracic and cardiovascular surgery.
[21] P. Argani,et al. Lymphocyte-rich well-differentiated liposarcoma: report of nine cases. , 1997, The American journal of surgical pathology.
[22] L. Guillou,et al. Well-differentiated inflammatory liposarcoma: an uncommon and easily overlooked variant of a common sarcoma. , 1997, The American journal of surgical pathology.
[23] C. Karakousis,et al. Soft tissue sarcomas in adults , 1994, CA: a cancer journal for clinicians.
[24] B Sundell,et al. Soft-tissue sarcomas. , 1979, British medical journal.
[25] L. Schwartz,et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). , 2009, European journal of cancer.
[26] H. Huland,et al. Tumor-associated eosinophilia in interleukin-2-treated patients: evidence of toxic eosinophil degranulation on bladder cancer cells , 2005, Journal of Cancer Research and Clinical Oncology.